PF-3512676 (CPG 7909)

PF-3512676 · Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-3512676 (CPG 7909), covering 2009-03-12 to 2017-03-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas [Phase 2]